(Q38883517)

7 September 2017

title

Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial (English)

1 reference

sulfadoxine/pyrimethamine

7 September 2017

0 references

0 references

0 references

0 references

1 reference

1

Grant Dorsey

1 reference

7 September 2017

3

Moses R Kamya

1 reference

7 September 2017

8

Philip J Rosenthal

1 reference

7 September 2017

6

Sarah G Staedke

1 reference

7 September 2017

4

Adithya Cattamanchi

1 reference

7 September 2017

Denise Njama

2

1 reference

7 September 2017

Daniel Kyabayinze

series ordinal

5

1 reference

7 September 2017

Anne Gasasira

series ordinal

7

1 reference

7 September 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

7 September 2017

1 reference

7 September 2017

volume

360

1 reference

7 September 2017

issue

9350

1 reference

7 September 2017

page(s)

2031-2038

1 reference

The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912021-6

7 January 2021

Averting a malaria disaster

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912021-6

7 January 2021

Systematic review of amodiaquine treatment in uncomplicated malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912021-6

7 January 2021

Can amodiaquine be resurrected?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912021-6

7 January 2021

Antimalarial drug resistance and combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912021-6

7 January 2021

Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912021-6

7 January 2021

Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912021-6

7 January 2021

Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912021-6

7 January 2021

The comparative efficacy of chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Kampala, Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912021-6

7 January 2021

No influence of age on infection complexity and allelic distribution in Plasmodium falciparum infections in Ndiop, a Senegalese village with seasonal, mesoendemic malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912021-6

7 January 2021

Structural and antigenic polymorphism of the 35- to 48-kilodalton merozoite surface antigen (MSA-2) of the malaria parasite Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912021-6

7 January 2021

Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912021-6

7 January 2021

Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912021-6

7 January 2021

The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912021-6

7 January 2021

Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912021-6

7 January 2021

Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912021-6

7 January 2021

African scientists discuss drug-resistant malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2912021-6

7 January 2021

10.1016/S0140-6736(02)12021-6

Identifiers

DOI

1 reference

7 September 2017

1 reference